Wernert N
Institute of Pathology, University of Bonn, Germany.
Virchows Arch. 1997 Jun;430(6):433-43. doi: 10.1007/s004280050053.
Since the work of Judah Folkman in the 1970s demonstrating the importance of vascularization on tumour growth the many roles played by tumour stroma have been demonstrated. Vascular endothelial growth factor/vascular permeability factor appears to be the main in vivo inducer of both stromal blood vessels and other components of the tumour stroma. Its action is probably mediated through its strong and long-lasting effect on microvascular permeability leading to fibrin extravasation and organisation ("tumours are wounds that do not heal"). During tumour invasion, stromal fibroblasts participate in the degradation of the extracellular matrix (ECM) by secreting matrix degrading proteases as well as their downstream-activators. Stroma derived factors such as scatter factor/hepatocyte growth factor as well as interactions between neoplastic cells and the ECM can play a role in both tumour cell migration and proliferation. The ECM may also act as a reservoir for growth factors. A novel transcription factor encoded by the c-ets 1 proto-oncogene is likely to be involved in the transcriptional regulation of both tumour vascularization and invasion. This contribution summarizes recent developments in the tumour stroma field.
自20世纪70年代朱达·福克曼的研究证明血管生成对肿瘤生长的重要性以来,肿瘤基质所起的多种作用已得到证实。血管内皮生长因子/血管通透因子似乎是肿瘤基质中血管及其他成分在体内的主要诱导因子。其作用可能是通过对微血管通透性产生强烈而持久的影响来介导的,从而导致纤维蛋白外渗和组织化(“肿瘤是不愈合的伤口”)。在肿瘤侵袭过程中,基质成纤维细胞通过分泌基质降解蛋白酶及其下游激活因子参与细胞外基质(ECM)的降解。基质衍生因子,如散射因子/肝细胞生长因子,以及肿瘤细胞与ECM之间的相互作用,在肿瘤细胞迁移和增殖中均可能发挥作用。ECM也可能作为生长因子的储存库。由c-ets 1原癌基因编码的一种新型转录因子可能参与肿瘤血管生成和侵袭的转录调控。本综述总结了肿瘤基质领域的最新进展。